logo
Debunking The '54-Year Life Expectancy' Claim For Autistic People

Debunking The '54-Year Life Expectancy' Claim For Autistic People

Forbes14-07-2025
Autistic people deserve better than a headline. Yet a widely circulated claim that autistic ... More individuals have an average life expectancy of just 54 years continues to echo across media outlets, high-impact journals, and even federal policy reports.
Autistic people deserve better than a headline. Yet a widely circulated claim that autistic individuals have an average life expectancy of just 54 years continues to echo across media outlets, high-impact journals, and even federal policy reports.
The source? A 2016 study by Hirvikoski et al. has been grossly misinterpreted and misapplied in both academic and public discourse. The reality is far more nuanced, and perpetuating this statistic is not only misleading but also harmful.
According to Andy Shih, Chief Science Officer at Autism Speaks, "Data from credible previous studies suggests a shorter average life expectancy for autistic adults when compared to their peers of about 17 years. However, taking the limitations of those studies into account, we cannot say that this finding is generalizable across the world."
What the Original Study Actually Said About Autistic People
The Hirvikoski study did not find that all autistic people die at 54. In fact, fewer than 3% of the autistic cohort died during the study period, which renders it methodologically incorrect to extrapolate a mean age of death from such a small subset.
"In the 2016 study by Hirvikoski, the authors extrapolated a mean age of death from a small subset," said Kimberly Idoko, MD, Esq., a board-certified neurologist and certified coach. "That's statistically inappropriate, and it creates a distorted picture that doesn't reflect the true life expectancy of autistic people."
Gemma Williams, an academic researcher in the UK, echoed this sentiment. "Only around 3% of the autistic cohort died during the study, but only 0.91% of the non-autistic cohort died. We're still unclear on the percentage of autistic people in the wider population, but what's clear is that autistic people were more likely to have died from almost all types of medical conditions."
Recent studies, such as this 2023 Lancet Regional Health study, provide a more accurate representation of the disparity, showing a life expectancy gap between autistic and non-autistic adults that is significant but not as extreme as the 54-year claim.
The Real Consequences of Autistic Misrepresentation
In a recent open-access study published in JAMA Network Open, researchers Lauren Bishop and Brittany ... More N. Hand analyzed the citations of the Hirvikoski study. Over 70% of citing authors misrepresented their findings.
In a recent open-access study published in JAMA Network Open, researchers Dr. Lauren Bishop and Dr. Brittany N. Hand analyzed the citations of the Hirvikoski study.
Over 70% of citing authors misrepresented their findings. "We expected to find that a sizable minority of articles misrepresented Hirvikoski et al's findings based on our anecdotal experiences as readers, reviewers, and editors," said Dr. Hand. "However, we were surprised to see how widespread these misrepresentations really were."
This misinformation has not been contained within academia. "These misrepresentations have been perpetuated in really high-impact publications and news media," Hand explained. "They even appeared in reports to the U.S. Congress by the Department of Health and Human Services and a continuing education article from the CDC."
The implications are vast. "Misrepresenting mortality statistics for autistic people can cause psychological distress for autistic individuals and their families," Hand added. "Our autistic adult advisory board frequently raises concerns about this narrative." This misinformation can also lead to insurance denials, distorted retirement planning, and worsened stigma.
In her social work course, Dr. Bishop teaches this exact topic and notes that "most of my bachelor's- and master' s-level social work students make the very same interpretation mistakes that the citing authors in our study make." This isn't just about numbers; it's about how we shape perceptions and policies.
Overshadowing Urgent Health Priorities
This misplaced focus on a singular, misleading statistic diverts attention from the actual causes of health disparities. "Perhaps in part because of the misrepresentation of Hirvikoski et al.'s suicide findings," Bishop noted, "autism researchers have increasingly focused on suicide and suicidality instead of studying more prevalent causes of mortality, such as cardiovascular disease."
Ms. Williams points out that in the UK, autistic individuals face significant healthcare barriers, including sensory challenges and communication issues that often prevent them from accessing timely care. "Many autistic people don't get past primary care with problems that quickly escalate," she said. "Add to that background stigma and reduced opportunities to participate in school, work, and social lives, and it paints a bleak picture."
Shih agrees that more inclusive, long-term studies are needed. "Conducting studies like that led by Hirvikoski across every country would give us a more generalizable understanding of autism and aging," he said. "This would point to solutions and opportunities for improvement in these communities."
A More Responsible Narrative For Autistic People
So, how can we improve?
First, by recognizing the responsibilities of researchers, reviewers, and editors. "Authors have a responsibility not to oversensationalize the titles of their research articles to the point of inaccuracy," said Dr. Hand. "Reviewers and editors must check for this."
The term "premature mortality," used in the title of the Hirvikoski paper, is especially problematic. "There is not sufficient evidence from Hirvikoski et al., 2016 to support the idea that, at a population level, autistic people die prematurely," said Hand. Even researchers like Bishop and Hand have begun re-evaluating their own language use. "Now that we know better, we want to do better and start a conversation about it," Hand said.
Dr. Bishop encourages a shift in focus: "Lots of autistic people age well and live long, healthy lives. Health and aging outcomes among autistic people are incredibly heterogeneous. We can do a lot at the individual, family, community, and systems levels to support folks to age and live well."
Partnering with autistic people in the research process is also essential. "We need more information about autistic people's goals and priorities around aging," Hand emphasized. Bishop added that it's time to stop framing aging in autism as solely a problem. "Let's move toward studying healthy aging," she said.
What Comes Next
Shih emphasized that this is a global challenge: "Long-term, longitudinal studies are especially ... More critical to track autistic individuals across their lifespans. These must be fully inclusive, reflecting the full diversity of the autistic community."
Studies of aging in autism are still in their infancy. "Many autism researchers refer to 'aging' autistic populations as those aging into adulthood or middle age," Hand said. "The narrative needs to expand to include aging into and through older adulthood."
Bishop identified several critical, under-discussed issues: "Diagnosis in older adulthood, dementia, cardiovascular disease, reproductive health, and accommodating autistic older adults within the healthcare system all need more attention."
Shih emphasized that this is a global challenge: "Long-term, longitudinal studies are especially critical to track autistic individuals across their lifespans. These must be fully inclusive, reflecting the full diversity of the autistic community."
The myth of the 54-year life expectancy for autistic people has persisted long enough. "It's more important to reckon with reality than let small numbers in one study steer public thinking," said Williams. Responsible communication isn't just good science, it's good humanity.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

"Never Has America Been More Vulnerable" — People Are Horrified After RFK Jr. Announced He's Cutting $500 Million In Funding For mRNA Vaccines
"Never Has America Been More Vulnerable" — People Are Horrified After RFK Jr. Announced He's Cutting $500 Million In Funding For mRNA Vaccines

Yahoo

time18 minutes ago

  • Yahoo

"Never Has America Been More Vulnerable" — People Are Horrified After RFK Jr. Announced He's Cutting $500 Million In Funding For mRNA Vaccines

I'm not sure if you've heard, but everyone's least favorite Health and Human Services Secretary, RFK Jr., recently announced that he's cancelling $500 million in funding for mRNA vaccine development. mRNA vaccines, which stand for messenger ribonucleic acid (RNA), are "highly effective" and "safe," according to the National Council on Aging, a nonprofit organization that works to improve the health of older adults in the US. According to the Cleveland Clinic, the mRNA vaccine helps teach your body to fight infectious diseases. More specifically, mRNA technology is utilized in the COVID-19 vaccine, which infectious disease experts say is what helped to slow the 2020 COVID-19 outbreak in the US. In a now-viral X video, RFK Jr. tried to explain the funding cuts saying, "HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses." Twitter: @SecKennedy According to CBS News, RFK Jr. reiterated that "HHS supports safe, effective vaccines for every American who wants them." Related: In response to the news, Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations, recently said, "I don't think I've seen a more dangerous decision in public health in my 50 years in the business." Following these vaccine funding cuts, millions have expressed deep concern for the future of medicine, as well as the impact of future pandemics in the US. Here's how medical professionals, lawmakers, and citizens are reacting: Commonly, people threw some personal digs at RFK Jr., with one person calling him a "despicable quack." ...and a pediatric MD calling him an "anti-vaxx weirdo." Related: While other medical professionals directly contradicted RFK Jr.'s claims about the mRNA vaccine, calling them "simply false." And called out RFK Jr.'s "fundamental misunderstanding of immunology." Another infectious disease doctor argued that RFK Jr.'s decision came from "ideology" and "online anti vax talking points." Related: And this medical professional and health writer called mRNA vaccines "one of the most important tools we have for preventing future pandemics." Another person expressed their anger about "throwing away" years of research: Even politicians have weighed in, with Senator Reverend Raphael Warnock calling the funding cuts a "tragedy." Related: "Whatever your reason for not voting or voting 3rd party, I promise it wasn't worth destroying our country over," this person wrote. And this person made a scary observation, writing: "A diseased population is easier to control..." And finally, this Reddit user summed up what many are feeling: "Imagine being so privileged to have lived in a tiny slice of human history when MILLIONS of people have been spared from pyrogens at the hands of vaccines……only to be somehow convinced the answer to the threat humanity faces going forward is to stop researching the most proven and effective medicine mankind has ever known." What are your thoughts? Let us know in the comments below. Also in In the News: Also in In the News: Also in In the News:

‘Going To Cost Lives': Former Surgeon General Shocked By RFK's Latest Move
‘Going To Cost Lives': Former Surgeon General Shocked By RFK's Latest Move

Yahoo

time18 minutes ago

  • Yahoo

‘Going To Cost Lives': Former Surgeon General Shocked By RFK's Latest Move

Robert F. Kennedy Jr.'s shock decision to cancel nearly half a billion dollars' worth of research projects because they're based on mRNA technology horrified vaccine experts Tuesday, among them President Donald Trump's own former surgeon general. Jerome Adams, who served as the nation's 20th surgeon general during Trump's first term, warned on social media that the decision will have very real negative consequences. 'I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives,' he wrote. 'mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions.' Adams ended the missive with the 'head exploding' emoji. I've tried to be objective & non-alarmist in response to current HHS actions – but quite frankly this move is going to cost lives. mRNA technology has uses that go far beyond vaccines… and the vaccine they helped develop in record time is credited with saving millions. 🤯 — Jerome Adams (@JeromeAdamsMD) August 6, 2025 In another thread, Adams blamed politicized messaging around vaccination during the coronavirus pandemic for leading to a widespread public misunderstanding of what vaccines actually accomplish. People believed that 'if you get this vaccine you won't get COVID,' said Adams, when the real aim was to prevent severe cases of the disease. Messenger RNA, or mRNA, technology has potential far beyond COVID. At Emory University, for instance, researchers are looking into using mRNA technology to train the immune system to cure cancer and chronic infections, thanks to a $24.8 million federal grant. The three-year program was funded by the Advanced Research Projects Agency for Health, or ARPA-H, which Kennedy merged with the Biomedical Advanced Research and Development Authority, or BARDA, in March — only to announce Tuesday he'd be pulling the funding for BARDA's mRNA investments. The inaugural director of ARPA-H, Dr. Renee Wegrzyn, was fired by the Trump administration in February amid mass layoffs at the Department of Health and Human Services and the Centers for Disease Control and Prevention. Tiba Biotech, another research company that saw its HHS contracts terminated Tuesday, is investigating using mRNA to combat tick-borne diseases. Thanks to climate change, more ticks are surviving through warmer winters, leading to a sharp increase in tick-borne illnesses. Mike Osterholm, a University of Minnesota expert on infectious diseases and pandemic preparations, told The Associated Press the decision on mRNA research is a historically bad one. 'I don't think I've seen a more dangerous decision in public health in my 50 years in the business,' he said. Related... RFK Jr. Cancels $500 Million In Funding For Vaccine Development 800,000 Vaccine Doses The U.S. Pledged To Send To Africa Are About To Expire Instead RFK Jr.'s Stunning Claim About Black People And Vaccines Sparks Concern From Medical Experts RFK Jr. Keeps Telling A Flat-Out Lie About Childhood Vaccines — And Doctors Are Sick Of It

Walmart Employee's 'Magic' Side Hustle Surpasses $1 Million
Walmart Employee's 'Magic' Side Hustle Surpasses $1 Million

Entrepreneur

time20 minutes ago

  • Entrepreneur

Walmart Employee's 'Magic' Side Hustle Surpasses $1 Million

This Side Hustle Spotlight Q&A features 35-year-old New York City-based entrepreneur Mehek Khera. Khera is the founder and CEO of Niramaya Foods, a snack brand "rooted in wellness and inspired by Indian heritage." At the age of 24, Khera left New Delhi, India and immigrated to the U.S., where she landed a job at Walmart. Then burnout and health issues motivated her to start a health-forward side hustle. Niramaya is hitting $1 million in revenue for the first time in 2025. Learn how Khera transformed Niramaya into the successful business behind Naan pretzels and dips, here. Responses have been edited for length and clarity. Image Credit: Niramaya Foods. Mehek Khera. Want to read more stories like this? Subscribe to Money Makers, our free newsletter packed with creative side hustle ideas and successful strategies. Sign up here. What was your day job or primary occupation when you started your side hustle? I was working in retail at Walmart ecommerce, managing the category and supply chain for beauty and apparel. It was fast-paced, high-pressure and fulfilling in many ways — but over time, the long hours, lack of real food and stress began to take a toll on my body and mind. Related: This 26-Year-Old's Side Hustle Turned Full-Time Business Led to $100,000 in 2.5 Months and Is On Track for $2.5 Million in 2025 When did you start your side hustle, and where did you find the inspiration for it? Niramaya began to form in 2020, during a season of burnout and health struggles. I was dealing with chronic, undiagnosed autoimmune conditions and couldn't find answers. I left my job and turned to nutrition school — and through that, rediscovered the healing power of the foods I grew up with: vibrant dals, functional spices, sabzis made from fresh vegetables. I realized those recipes, passed down through generations, were medicine in themselves, and yet, I couldn't find them on any shelf in a way that felt clean, convenient or modern. That gap between culture and convenience, tradition and today, became the foundation for Niramaya. What were some of the first steps you took to get your side hustle off the ground? How much money/investment did it take to launch? I started in my kitchen, playing with recipes, taking feedback seriously and testing early versions at local markets. I knew I couldn't do this casually, so I saved up about $50,000 over two years to afford the minimum order quantities for our first co-manufacturer. I researched tirelessly, made hundreds of phone calls and eventually found a partner that aligned with our mission. We developed early packaging, launched a small website and put real products into people's hands. That's when the magic started. Related: This 29-Year-Old's Side Hustle Brought People 'to the Dark Green Side.' It Made $10,000 Within 2 Days and Sees 6 Figures a Month. Image Credit: Courtesy of Niramaya Foods Are there any free or paid resources that were especially helpful? Founder networks like Startup CPG, Naturally Network and SKU Accelerator made a world of difference. Slack groups for CPG founders were fast, brutally honest and incredibly supportive. On the tools side: Notion for tracking everything, Canva for design, QuickBooks for finances. But the most valuable resource by far? Talking to consumers face-to-face during demos. No software can replace that. If you could go back and change one process or approach, what would it be? I wouldn't change the path — every challenge taught me something I needed. But I would better prepare for the sheer resource drain. Budget twice the money and give yourself twice the time. Everything takes longer and costs more than you think — and that's not a flaw: It's just the nature of the game. Related: They Started a Side Hustle Producing an 'Obvious' Food Item. It Hit $300,000 Monthly Revenue Fast — On Track for Over $20 Million in 2025. What's something about this side hustle turned business that surprised or challenged you the most? How capital-intensive retail really is. Getting onto shelves is just the start — then comes the real work of driving velocity, educating the shopper and staying top-of-mind. Another challenge was re-educating people about Indian food. So many assume it's just "heavy curry." But our cuisine is so much more: vibrant, clean, gut-friendly, plant-forward. Translating that truth through packaging, product and language has been both a challenge and a privilege. Can you recall a specific moment when something went wrong — how did you handle it? At one of our early retail partners, our dips were priced too high and placed on the very top shelf — almost invisible to the consumer. Rather than panic, I calmly reached out to the buyer with sales data and shelf psychology insights and offered to support with demos and social posts if they would consider revisiting price and placement. They agreed. That moment reminded me that being proactive, respectful and solutions-oriented goes a long way in retail. Image Credit: Courtesy of Niramaya Foods How long did it take to see consistent revenue? We started seeing steady traction around nine months in. We began with smaller independents, a few regional stores and a lot of in-person events. It was grassroots, but it taught me how to listen, adapt and scale responsibly. What does growth and revenue look like today? Today, Niramaya is available in over 1,200 retail doors across the country, including Sprouts, Albertsons and a strong base of New York City independents. This will be our first year in seven figures. We're launching new SKUs and doubling down on retailers who believe in what we're building. What do you enjoy most about running this business? The deep creative satisfaction of building something that feels true and seeing it touch people. When someone says, "I've never tasted anything so clean and bold at once," I know we're doing something meaningful. We're not just selling food: We're shifting the perception of Indian flavors and bringing more people into the fold. Related: Tired of 'Culturally Obtuse' Products, This 27-Year-Old Took His Side Hustle From $1,000 a Month to 7-Figure Revenue: 'Pick the Right Opportunity to Pursue' What's your best piece of specific, actionable business advice? Start before you feel "ready." But don't build in a bubble. Get feedback constantly, especially from your customers. Stay lean. Build trust with your partners. Don't be afraid to ask dumb questions. And remember — relationships will carry you farther than any marketing campaign. Be generous, be honest and follow through. Ready to break through your revenue ceiling? Join us at Level Up, a conference for ambitious business leaders to unlock new growth opportunities.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store